Trials / Unknown
UnknownNCT02265562
Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy
Evaluation of the Effect of Rectal Misoprostol on Blood Loss During Abdominal Hysterectomy: A Double Blind Randomized Controlled Trial.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Hysterectomy, as any major operation, can cause complications, as hemorrhage which may occur in some cases and sometimes requiring blood transfusion. Recent study proved that misoprostol success in reducing blood loss during total abdominal hysterectomy when used once before the surgery.
Detailed description
In this study we tried to assess the efficacy of misoprostol in minimize blood loss during hysterectomy when used as single preoperative dose via rectal route. The reduction of blood flow may be due to the combined effect of myometrial contraction and vasoconstrictive effect
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol | 60 minutes before the surgery 400 μg of misoprostol (2 tablets of 200 μg) inserted rectally |
| DRUG | Placebo | 60 minutes before the surgery 2 tablet of placebo inserted rectally |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-05-01
- Completion
- 2015-06-01
- First posted
- 2014-10-16
- Last updated
- 2014-10-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02265562. Inclusion in this directory is not an endorsement.